C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2011
11/24/2011	US20110287058 Universal GM-CSF Expressing Bystander Human Cell Line
11/24/2011	US20110287055 Compositions comprising prfa* mutant listeria and mehtods of use thereof
11/24/2011	US20110287053 Recombinant Foot and Mouth Disease Vaccine
11/24/2011	US20110287051 Parapoxvirus vectors
11/24/2011	US20110287050 Recombinant koi herpesvirus (khv) or cyprinid herpesvirus 3 (cyhv-3) and a vaccine for the prevention of a disease caused by khv/cyhv-3 in cyprinus carpio carpio or cyprinus carpio koi
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides
11/24/2011	US20110287045 Enhanced immune response against infections
11/24/2011	US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods
11/24/2011	US20110287037 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
11/24/2011	US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels
11/24/2011	US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer
11/24/2011	US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same
11/24/2011	US20110287010 Diagnostic methods and markers
11/24/2011	US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/24/2011	US20110286983 Long lasting drug formulations
11/24/2011	US20110286982 Glucagon analogues
11/24/2011	US20110286981 Glucagon analogues
11/24/2011	US20110286978 Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof
11/24/2011	US20110286975 Systems and methods for magnetic guidance and patterning of materials
11/24/2011	US20110286973 Methods for introducing heterologous cells into fish
11/24/2011	US20110286972 Virus growing in hypoxic cell or virus vector expressing gene therein
11/24/2011	US20110286934 Membrane transduction peptides, polynucleotides, and methods
11/24/2011	US20110286931 Cardiac arrhythmia treatment methods and biological pacemaker
11/24/2011	US20110284161 Biological glue and method for obtaining a biological glue
11/24/2011	US20110283945 Sex-peptides resistant to proteolytic degradation and their use in biological control of insects
11/24/2011	CA2836315A1 Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas
11/24/2011	CA2801897A1 Marker vaccine for classical swine fever
11/24/2011	CA2800173A1 Bi-specific fusion proteins
11/24/2011	CA2800150A1 Influenza virus reassortment method
11/24/2011	CA2800065A1 Reagents and methods for treating cancer
11/24/2011	CA2800018A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
11/24/2011	CA2799795A1 System and method of producing volatile organic compounds from fungi
11/24/2011	CA2799614A1 Altered leaf morphology and enhanced agronomic properties in plants
11/24/2011	CA2799599A1 Universally applicable lysis buffer and processing methods for the lysis of bodily samples
11/24/2011	CA2799559A1 Production of dha and other lc-pufas in plants
11/24/2011	CA2799050A1 Udp-glucose-4-epimerase useful for improving agronomic performance of plants
11/24/2011	CA2798988A1 Novel dna-binding proteins and uses thereof
11/24/2011	CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo
11/24/2011	CA2798055A1 Parapoxvirus vectors containing rabies virus antigen
11/23/2011	EP2388590A1 PD-1, a receptor for B7-4, and uses thereof
11/23/2011	EP2388340A1 Method of detecting H5 or H7 avian influenza virus
11/23/2011	EP2388332A1 Process for the production of delta5-unsaturated fatty acids in transgenic organisms
11/23/2011	EP2388331A1 Constitutive promoter
11/23/2011	EP2388330A1 Liver engrafting cells, assays, and uses thereof
11/23/2011	EP2388329A2 Fusion proteins the process to preparation and utilization in expression systems of recombinant proteins
11/23/2011	EP2388328A1 Oligomeric compounds and compositions for the use in modulation of micrornas
11/23/2011	EP2388327A1 Oligomeric compounds and compositions for the use in modulation of micrornas
11/23/2011	EP2388326A1 Modulation of glucagon receptor expression
11/23/2011	EP2388325A1 Method for isolating small RNA-molecules using HC-Pro protein
11/23/2011	EP2388324A1 Control material for nucleic acid tests
11/23/2011	EP2388323A2 Humanized anti-9 integrin antibodies and the uses thereof
11/23/2011	EP2388322A1 Enzymatic preparation containing thermostable dna polymerase, process for producing same, and method for detecting analyte organism
11/23/2011	EP2388321A1 Novel expression vector
11/23/2011	EP2388320A1 Anti-hs6st2 antibody and use thereof
11/23/2011	EP2388319A1 Method for specifying habitat area of insect
11/23/2011	EP2388318A1 Antisense modulation of connective tissue growth factor expression
11/23/2011	EP2388317A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
11/23/2011	EP2388316A2 Aldolases, nucleic acids encoding them and methods for making and using them
11/23/2011	EP2388312A1 Universally applicable lysis buffer and processing methods for the lysis of bodily samples
11/23/2011	EP2388277A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388276A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388275A2 An aglycosylated IgG1 antibody to CD3
11/23/2011	EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
11/23/2011	EP2388267A1 Alpha-amylase mutants
11/23/2011	EP2388266A2 Fusion molecules and IL-15 variants
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388016A1 Non-viral nucleic acid molecules delivery systems
11/23/2011	EP2388015A1 DNA expression vectors and methods of use
11/23/2011	EP2387716A2 Ets-2 biomarkers for fibrotic diseases and uses thereof
11/23/2011	EP2387613A2 Plant transformation using dna minicircles
11/23/2011	EP2387612A1 Method of inhibiting proliferation of hepatic stellate cells
11/23/2011	EP2387611A1 Diagnosis and treatment of autism spectrum disorders
11/23/2011	EP2387610A2 METHODS AND KITS TO GENERATE miRNA- AND small RNA-EXPRESSING VECTORS, AND ITS APPLICATION TO DEVELOP LENTIVIRAL EXPRESSION LIBRARIES
11/23/2011	EP2387609A2 Non-embryonic stem cells and uses thereof
11/23/2011	EP2387581A1 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes
11/23/2011	EP2377926A9 Chondrocyte-like cell, and method for producing same
11/23/2011	EP2348111A9 PROBES FOR DETECTING MUTATIONS OF kRas GENE, LIQUICHIP AND DETECTION METHODS THEREOF
11/23/2011	EP2121929B1 Targeted delivery of sirna
11/23/2011	EP2104736B1 Mir-126 regulated genes and pathways as targets for therapeutic intervention
11/23/2011	EP1836223B1 Method for identifying a nucleic acid encoding a hemopexin-like structure which specifically binds a predetermined target molecule.
11/23/2011	EP1817411B1 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
11/23/2011	EP1773997B1 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
11/23/2011	EP1746156B1 Probe and primer for tubercle bacillus detection, and method of detecting human tubercle bacillus therewith
11/23/2011	EP1720909B1 Anti-abeta antibody
11/23/2011	EP1678305B1 Protozoan strain of the species leishmania infantum of reduced virulence and use thereof
11/23/2011	EP1644734B1 Method for assaying protein-protein interaction
11/23/2011	EP1592786B1 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
11/23/2011	EP1578903B1 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
11/23/2011	EP1532269B1 1l1rl-1 as a cardiovascular disease marker
11/23/2011	EP1509541B1 Novel recombinant anticoagulant proteins
11/23/2011	EP1504103B1 Promoters having a modified transcription efficiency and derived from methylotrophic yeast
11/23/2011	EP1476561B1 Amplifying repetitive nucleic acid sequences
11/23/2011	EP1435787B1 Nestin-expressing hair follicle stem cells
11/23/2011	EP1390482B1 Compositions and methods for random nucleic acid mutagenisis
11/23/2011	EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011	EP1297109B1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same
11/23/2011	EP0932688B1 Chrysosporium cellulase and methods of use
11/23/2011	CN1993467B Gene related with prostate disease and encoding polypeptides and its application
11/23/2011	CN1902229B IL-18 binding proteins

1 ... 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 ... 4023